04/2026 – AstronDX Technologies is happy to announce the regulatory approval of the LyteStar™ Arbovirus ZCD kit for detection and differentiation of Dengue, Chikungunya and Zika virus in Thailand. The approval from the Thai Food and Drug Administration (FDA) in April 2026 follows the market introduction and approval by the Malaysian Medical Device Authority (MDA) in 2024 and marks another milestone in ADX mission to address a growing demand for accurate, high performance diagnostics for tropical and emerging diseases.
The LyteStar™ Arbovirus ZCD RT-PCR Kit 1.0 is intended for the simultaneous and specific detection of four serotypes of Dengue (DENV 1-4), Chikungunya and Zika virus RNA in human serum specimens. The LyteStar™ Arbovirus ZCD RT-PCR Kit 1.0 is a single-tube three-target assay targeting the three-prime untranslated region (3’UTR) for Dengue virus (DENV), the non-structural protein 2 (NSP2) gene for Chikungunya virus (CHIKV) and the envelope (E) gene for Zika virus (ZIKV).
